TNYA
NASD Tenaya Therapeutics, Inc.$0.5675 ↑ +0.0018 (+0.32%) Trading Up from the previous close of $0.5657
- YTD change
- -20.24%
- vs 20-day SMA
- -12.45%
- vs 200-day SMA
- -23.33%
Price ranges
Price & Performance
-0.13 (-18.56%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 98.2% away from all-time highs of $32.0000
- TNYA is down 20% since the beginning of the year
- TNYA is down 65% over the past 12 months
- TNYA is down 19% over the past 1 month
- 11% of all TNYA investors are betting against TNYA
TNYA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -64.6%.
- Previous minute
- -$0.0024
- Last hour
- -$0.0125
- Last 5 days
- -8.47%
- vs 8-day SMA
- -7.82%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. Its programs include TN-201, TN-401, and TN-301. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Newell Olson in 2016 and is headquartered in South San Francisco, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.